Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
ASPC.adipocyte_capillary_interface: Meta traits — page 6
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,040 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 5,001–5,288 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 5001 | S100G levels | PROLV001772 | 4.73e-03 | Protein levels | Hepatocyte | 9 | 1 | 3 | 10 | |
| 5002 | ADA2/COMP ratio | PRORT000022 | 4.71e-03 | Protein ratios | Myeloid | 56 | 2 | 5 | 10 | |
| 5003 | CPA1/CTRB1 ratio | PRORT000719 | 4.71e-03 | Protein ratios | Pancreatic epithelium | 13 | 0 | 2 | 7 | |
| 5004 | ATOX1/SPARC ratio | PRORT000152 | 4.71e-03 | Protein ratios | Myeloid | 10 | 1 | 6 | 11 | |
| 5005 | F2R/TMSB10 ratio | PRORT001084 | 4.69e-03 | Protein ratios | Myeloid | 9 | 1 | 7 | 10 | |
| 5006 | ATG4A/NSFL1C ratio | PRORT000149 | 4.68e-03 | Protein ratios | Hematopoietic progenitor | 0 | 3 | 5 | 9 | |
| 5007 | CD8A levels | PROLV000361 | 4.67e-03 | Protein levels | Lymphocyte | 149 | 2 | 10 | 16 | |
| 5008 | CXCL5/MESD ratio | PRORT000828 | 4.66e-03 | Protein ratios | Lymphocyte | 2 | 3 | 11 | 25 | |
| 5009 | FADD/PPP1R2 ratio | PRORT001109 | 4.65e-03 | Protein ratios | Myeloid | 14 | 1 | 7 | 13 | |
| 5010 | DCXR/KYNU ratio | PRORT000877 | 4.64e-03 | Protein ratios | Hepatocyte | 13 | 3 | 10 | 15 | |
| 5011 | CXCL11/ITGB1BP2 ratio | PRORT000818 | 4.63e-03 | Protein ratios | Muscle / cardiac | 1 | 3 | 8 | 15 | |
| 5012 | HNRNPK/USP8 ratio | PRORT001293 | 4.62e-03 | Protein ratios | B / plasma cell | 0 | 2 | 9 | 18 | |
| 5013 | CLEC4G/NELL2 ratio | PRORT000662 | 4.59e-03 | Protein ratios | Myeloid | 35 | 5 | 16 | 39 | |
| 5014 | CD160/NCR1 ratio | PRORT000378 | 4.59e-03 | Protein ratios | Lymphocyte | 58 | 2 | 12 | 27 | |
| 5015 | CRTAM/ICAM3 ratio | PRORT000770 | 4.59e-03 | Protein ratios | Lymphocyte | 23 | 2 | 20 | 46 | |
| 5016 | BCAM/LGALS4 ratio | PRORT000210 | 4.53e-03 | Protein ratios | Hepatocyte | 31 | 1 | 7 | 4 | |
| 5017 | CASP3/MESD ratio | PRORT000315 | 4.52e-03 | Protein ratios | Myeloid | 0 | 2 | 8 | 17 | |
| 5018 | FOLR2 levels | PROLV000823 | 4.52e-03 | Protein levels | Myeloid | 134 | 3 | 10 | 11 | |
| 5019 | FCRL5 levels | PROLV000786 | 4.49e-03 | Protein levels | B / plasma cell | 201 | 5 | 17 | 23 | |
| 5020 | VEGFC/ZBTB16 ratio | PRORT001859 | 4.48e-03 | Protein ratios | Muscle / cardiac | 10 | 4 | 9 | 26 | |
| 5021 | IRAG2/TBC1D23 ratio | PRORT001367 | 4.44e-03 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 19 | |
| 5022 | DECR1/STX8 ratio | PRORT000884 | 4.43e-03 | Protein ratios | Hepatocyte | 9 | 2 | 8 | 15 | |
| 5023 | Psychiatric care | PSYCH000015 | 4.39e-03 | Psychiatric | Neural / glial | 9 | 3 | 11 | 16 | |
| 5024 | NUCB2/RSPO3 ratio | PRORT001606 | 4.36e-03 | Protein ratios | Muscle / cardiac | 6 | 2 | 6 | 12 | |
| 5025 | SPRY2/YTHDF3 ratio | PRORT001812 | 4.35e-03 | Protein ratios | Myeloid | 0 | 4 | 9 | 21 | |
| 5026 | MBL2 levels | PROLV001282 | 4.35e-03 | Protein levels | B / plasma cell | 15 | 2 | 7 | 23 | |
| 5027 | Autoimmune disease | IMMUN000023 | 4.35e-03 | Immunologic | Lymphocyte | 287 | 2 | 12 | 15 | |
| 5028 | JCHAIN levels | PROLV001126 | 4.33e-03 | Protein levels | B / plasma cell | 124 | 3 | 13 | 34 | |
| 5029 | CD300E levels | PROLV000331 | 4.32e-03 | Protein levels | Myeloid | 202 | 2 | 7 | 8 | |
| 5030 | CD63/EDAR ratio | PRORT000486 | 4.30e-03 | Protein ratios | Myeloid | 0 | 5 | 10 | 12 | |
| 5031 | FOXO3/MAP3K5 ratio | PRORT001178 | 4.28e-03 | Protein ratios | Gastrointestinal epithelium | 0 | 1 | 11 | 19 | |
| 5032 | Cancer, Kidney | MALIG000016 | 4.26e-03 | Malignancy | Pancreatic epithelium | 1 | 0 | 6 | 12 | |
| 5033 | PRSS8 levels | PROLV001648 | 4.24e-03 | Protein levels | Epithelial | 26 | 1 | 5 | 8 | |
| 5034 | Hashimoto thyroiditis | IMMUN000028 | 4.24e-03 | Immunologic | Neural / glial | — | 2 | 4 | 8 | |
| 5035 | ACHE levels | PROLV000012 | 4.23e-03 | Protein levels | Hepatocyte | 125 | 2 | 8 | 15 | |
| 5036 | S100A11/S100A12 ratio | PRORT001753 | 4.23e-03 | Protein ratios | B / plasma cell | 25 | 4 | 17 | 38 | |
| 5037 | AHSG levels | PROLV000065 | 4.19e-03 | Protein levels | Hepatocyte | 49 | 2 | 9 | 25 | |
| 5038 | CNDP1/F9 ratio | PRORT000678 | 4.14e-03 | Protein ratios | Hepatocyte | 68 | 1 | 9 | 4 | |
| 5039 | NELL2/SEZ6L ratio | PRORT001585 | 4.14e-03 | Protein ratios | Lymphocyte | 2 | 4 | 16 | 31 | |
| 5040 | ITGB6 levels | PROLV001115 | 4.13e-03 | Protein levels | Muscle / cardiac | 34 | 5 | 10 | 18 | |
| 5041 | ARNT levels | PROLV000144 | 4.12e-03 | Protein levels | Myeloid | 24 | 3 | 9 | 11 | |
| 5042 | FCRL6/KLRD1 ratio | PRORT001138 | 4.12e-03 | Protein ratios | Lymphocyte | 19 | 5 | 13 | 39 | |
| 5043 | Household size | SOCIO000011 | 4.12e-03 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 5044 | IL2RA/NCR1 ratio | PRORT001351 | 4.10e-03 | Protein ratios | Lymphocyte | 29 | 3 | 8 | 38 | |
| 5045 | MYBPC1 levels | PROLV001356 | 4.08e-03 | Protein levels | Muscle / cardiac | 18 | 4 | 9 | 21 | |
| 5046 | CLEC1B/HBEGF ratio | PRORT000638 | 4.08e-03 | Protein ratios | Myeloid | 60 | 2 | 15 | 15 | |
| 5047 | Consultant specialty, dermatology | DERMA000005 | 4.07e-03 | Dermatologic | B / plasma cell | 5 | 0 | 2 | 9 | |
| 5048 | PGLYRP1 levels | PROLV001546 | 4.06e-03 | Protein levels | Myeloid | 82 | 4 | 8 | 9 | |
| 5049 | MICB_MICA/TEK ratio | PRORT001533 | 4.05e-03 | Protein ratios | Myeloid | 65 | 3 | 12 | 25 | |
| 5050 | ZNF830 levels | PROLV002212 | 4.04e-03 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 5051 | BCR/FOXO1 ratio | PRORT000224 | 4.04e-03 | Protein ratios | Hepatocyte | 15 | 3 | 12 | 23 | |
| 5052 | MAX/TDRKH ratio | PRORT001504 | 4.00e-03 | Protein ratios | Myeloid | 0 | 4 | 11 | 11 | |
| 5053 | CA9/CBLIF ratio | PRORT000290 | 3.99e-03 | Protein ratios | Pancreatic epithelium | 47 | 0 | 4 | 7 | |
| 5054 | Cancer, Lip | MALIG000017 | 3.98e-03 | Malignancy | Lymphocyte | 0 | 3 | 11 | 39 | |
| 5055 | ABHD14B/APRT ratio | PRORT000003 | 3.96e-03 | Protein ratios | Myeloid | 8 | 4 | 11 | 18 | |
| 5056 | DAB2/VASH1 ratio | PRORT000842 | 3.92e-03 | Protein ratios | Hepatocyte | 1 | 2 | 11 | 23 | |
| 5057 | CCN2/TPP1 ratio | PRORT000370 | 3.91e-03 | Protein ratios | Myeloid | 57 | 3 | 8 | 16 | |
| 5058 | DKK1/PDGFA ratio | PRORT000898 | 3.90e-03 | Protein ratios | Hematopoietic progenitor | 4 | 3 | 10 | 26 | |
| 5059 | Mouth ulcers | DENTA000010 | 3.85e-03 | Dental | Myeloid | 194 | 4 | 15 | 36 | |
| 5060 | DIABLO/DOK2 ratio | PRORT000889 | 3.85e-03 | Protein ratios | Hepatocyte | 1 | 4 | 9 | 20 | |
| 5061 | CXCL5/PPIB ratio | PRORT000830 | 3.81e-03 | Protein ratios | Platelet | 1 | 6 | 12 | 30 | |
| 5062 | HSBP1 levels | PROLV000992 | 3.80e-03 | Protein levels | Muscle / cardiac | 19 | 7 | 10 | 27 | |
| 5063 | KLK13 levels | PROLV001153 | 3.78e-03 | Protein levels | Myeloid | 106 | 2 | 10 | 12 | |
| 5064 | MRPL33 levels | PROLV001339 | 3.76e-03 | Protein levels | Hepatocyte | 21 | 3 | 13 | 11 | |
| 5065 | CEP43/USP8 ratio | PRORT000602 | 3.73e-03 | Protein ratios | Myeloid | 0 | 2 | 8 | 27 | |
| 5066 | ART3/GPC1 ratio | PRORT000144 | 3.73e-03 | Protein ratios | Muscle / cardiac | 13 | 1 | 5 | 9 | |
| 5067 | GYS1/PPP1R2 ratio | PRORT001255 | 3.71e-03 | Protein ratios | Melanocyte | 0 | 1 | 5 | 12 | |
| 5068 | CD22/TCL1A ratio | PRORT000404 | 3.71e-03 | Protein ratios | B / plasma cell | 71 | 3 | 13 | 24 | |
| 5069 | CD101 levels | PROLV000308 | 3.70e-03 | Protein levels | Lymphocyte | 57 | 2 | 17 | 43 | |
| 5070 | BCR/PLXNA4 ratio | PRORT000229 | 3.67e-03 | Protein ratios | Lymphocyte | 3 | 1 | 6 | 25 | |
| 5071 | Medication, thyroid | ENDOC000002 | 3.63e-03 | Endocrine | Lymphocyte | 202 | 1 | 13 | 19 | |
| 5072 | GNLY levels | PROLV000905 | 3.62e-03 | Protein levels | Lymphocyte | 91 | 2 | 14 | 32 | |
| 5073 | ALCAM/ICAM3 ratio | PRORT000071 | 3.61e-03 | Protein ratios | Hepatocyte | 12 | 2 | 6 | 14 | |
| 5074 | CD27 levels | PROLV000324 | 3.57e-03 | Protein levels | B / plasma cell | 60 | 3 | 16 | 24 | |
| 5075 | STX6 levels | PROLV001969 | 3.55e-03 | Protein levels | Lymphocyte | 0 | 3 | 10 | 16 | |
| 5076 | ULBP2 levels | PROLV002139 | 3.55e-03 | Protein levels | Granulosa cell | 11 | 0 | 4 | 7 | |
| 5077 | CD79B/TNFRSF4 ratio | PRORT000514 | 3.54e-03 | Protein ratios | B / plasma cell | 45 | 3 | 16 | 20 | |
| 5078 | DIABLO/GRAP2 ratio | PRORT000890 | 3.53e-03 | Protein ratios | Muscle / cardiac | 1 | 3 | 10 | 20 | |
| 5079 | PIK3AP1/PSMG3 ratio | PRORT001664 | 3.51e-03 | Protein ratios | Lymphocyte | 1 | 1 | 6 | 9 | |
| 5080 | PPME1/PSMD9 ratio | PRORT001700 | 3.50e-03 | Protein ratios | Hepatocyte | 3 | 3 | 13 | 27 | |
| 5081 | CD163/ICAM1 ratio | PRORT000381 | 3.50e-03 | Protein ratios | Myeloid | 21 | 5 | 19 | 38 | |
| 5082 | SRPK2/VASH1 ratio | PRORT001815 | 3.49e-03 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 25 | |
| 5083 | CRELD2/F2R ratio | PRORT000755 | 3.46e-03 | Protein ratios | Hematopoietic progenitor | 15 | 2 | 7 | 13 | |
| 5084 | CLEC4G/LGALS4 ratio | PRORT000660 | 3.46e-03 | Protein ratios | Myeloid | 26 | 2 | 10 | 19 | |
| 5085 | IL6 levels | PROLV001077 | 3.46e-03 | Protein levels | Myeloid | 66 | 2 | 5 | 10 | |
| 5086 | HLA-A levels | PROLV000972 | 3.40e-03 | Protein levels | Myeloid | 143 | 3 | 11 | 29 | |
| 5087 | CEP43/MPHOSPH8 ratio | PRORT000599 | 3.39e-03 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 5088 | TCL1A levels | PROLV002002 | 3.39e-03 | Protein levels | B / plasma cell | 115 | 2 | 6 | 13 | |
| 5089 | EDAR/F2R ratio | PRORT000969 | 3.37e-03 | Protein ratios | Platelet | 43 | 3 | 13 | 27 | |
| 5090 | CD58/IFNGR1 ratio | PRORT000473 | 3.36e-03 | Protein ratios | Myeloid | 9 | 2 | 6 | 12 | |
| 5091 | Social and economic stability | SOCIO000028 | 3.30e-03 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 5092 | CDKN1A/TACC3 ratio | PRORT000572 | 3.29e-03 | Protein ratios | B / plasma cell | 20 | 4 | 12 | 29 | |
| 5093 | ACE2/MME ratio | PRORT000012 | 3.29e-03 | Protein ratios | Hepatocyte | 40 | 1 | 5 | 9 | |
| 5094 | DBI/EDAR ratio | PRORT000861 | 3.29e-03 | Protein ratios | Myeloid | 37 | 3 | 6 | 16 | |
| 5095 | F2R/SPINT2 ratio | PRORT001083 | 3.25e-03 | Protein ratios | Muscle / cardiac | 13 | 4 | 13 | 28 | |
| 5096 | EPHB6/LAYN ratio | PRORT001037 | 3.18e-03 | Protein ratios | Muscle / cardiac | 6 | 2 | 3 | 13 | |
| 5097 | SCARF1/TNFRSF14 ratio | PRORT001762 | 3.18e-03 | Protein ratios | Vascular | 11 | 1 | 2 | 9 | |
| 5098 | MAVS/MYO9B ratio | PRORT001496 | 3.17e-03 | Protein ratios | Myeloid | 0 | 1 | 4 | 16 | |
| 5099 | BANK1/FOXO1 ratio | PRORT000204 | 3.16e-03 | Protein ratios | Muscle / cardiac | 2 | 3 | 9 | 19 | |
| 5100 | CDH17/PTPRM ratio | PRORT000550 | 3.15e-03 | Protein ratios | Lymphocyte | 10 | 1 | 14 | 25 | |
| 5101 | ITGB1BP2/TIA1 ratio | PRORT001389 | 3.14e-03 | Protein ratios | Lymphocyte | 21 | 4 | 12 | 27 | |
| 5102 | EFNA4/VWC2 ratio | PRORT000993 | 3.12e-03 | Protein ratios | Hepatocyte | 4 | 2 | 12 | 18 | |
| 5103 | DEFA1_DEFA1B/PTGDS ratio | PRORT000886 | 3.11e-03 | Protein ratios | Myeloid | 19 | 2 | 13 | 23 | |
| 5104 | CD300LF levels | PROLV000332 | 3.11e-03 | Protein levels | Myeloid | 40 | 2 | 8 | 17 | |
| 5105 | LGALS4 levels | PROLV001204 | 3.11e-03 | Protein levels | B / plasma cell | 26 | 1 | 9 | 12 | |
| 5106 | ICAM3/NOTCH1 ratio | PRORT001327 | 3.10e-03 | Protein ratios | Hepatocyte | 22 | 2 | 9 | 23 | |
| 5107 | CLEC4D/CLEC6A ratio | PRORT000654 | 3.10e-03 | Protein ratios | Lymphocyte | 4 | 3 | 13 | 35 | |
| 5108 | IL15/IL18BP ratio | PRORT001342 | 3.10e-03 | Protein ratios | Lymphocyte | 14 | 2 | 11 | 22 | |
| 5109 | CD300C/HAVCR2 ratio | PRORT000425 | 3.04e-03 | Protein ratios | Myeloid | 48 | 3 | 11 | 16 | |
| 5110 | Spondyloarthritis | IMMUN000044 | 3.04e-03 | Immunologic | Myeloid | 110 | 4 | 8 | 20 | |
| 5111 | AGXT/GSTA1 ratio | PRORT000052 | 3.03e-03 | Protein ratios | Hepatocyte | 24 | 1 | 7 | 7 | |
| 5112 | AK1/PEBP1 ratio | PRORT000063 | 3.01e-03 | Protein ratios | Myeloid | 0 | 1 | 3 | 9 | |
| 5113 | Nephritic syndrome | NEPHR000009 | 2.98e-03 | Nephrourologic | Lymphocyte | — | 2 | 9 | 21 | |
| 5114 | GYS1/TIA1 ratio | PRORT001256 | 2.98e-03 | Protein ratios | Hepatocyte | 13 | 3 | 12 | 19 | |
| 5115 | DKK1/ZBTB16 ratio | PRORT000907 | 2.97e-03 | Protein ratios | Myeloid | 4 | 3 | 11 | 13 | |
| 5116 | Hypothyroidism | ENDOC000021 | 2.94e-03 | Endocrine | Lymphocyte | 371 | 1 | 12 | 20 | |
| 5117 | Excessive sweating | DERMA000029 | 2.89e-03 | Dermatologic | Myeloid | 4 | 1 | 3 | 3 | |
| 5118 | HGF levels | PROLV000965 | 2.88e-03 | Protein levels | Neural / glial | 29 | 4 | 13 | 15 | |
| 5119 | CEACAM8 levels | PROLV000394 | 2.85e-03 | Protein levels | Myeloid | 75 | 2 | 11 | 14 | |
| 5120 | GZMH/KLRD1 ratio | PRORT001264 | 2.84e-03 | Protein ratios | Lymphocyte | 35 | 3 | 13 | 36 | |
| 5121 | Lymphatic disorder | HEMAT000020 | 2.83e-03 | Hematologic | Myeloid | 0 | 1 | 7 | 9 | |
| 5122 | CD1C/CD207 ratio | PRORT000391 | 2.83e-03 | Protein ratios | Myeloid | 46 | 3 | 9 | 13 | |
| 5123 | CLEC4G/KDR ratio | PRORT000658 | 2.82e-03 | Protein ratios | Myeloid | 37 | 4 | 14 | 22 | |
| 5124 | EDAR/TXNDC5 ratio | PRORT000984 | 2.80e-03 | Protein ratios | Myeloid | 50 | 2 | 7 | 16 | |
| 5125 | FCER2 levels | PROLV000777 | 2.80e-03 | Protein levels | B / plasma cell | 112 | 3 | 9 | 24 | |
| 5126 | CLEC11A levels | PROLV000445 | 2.77e-03 | Protein levels | Hematopoietic progenitor | 65 | 3 | 5 | 10 | |
| 5127 | HBEGF/PDGFA ratio | PRORT001268 | 2.76e-03 | Protein ratios | Myeloid | 63 | 2 | 9 | 13 | |
| 5128 | CEACAM6 levels | PROLV000393 | 2.75e-03 | Protein levels | Myeloid | 116 | 2 | 7 | 11 | |
| 5129 | CLSTN2 levels | PROLV000464 | 2.75e-03 | Protein levels | Hepatocyte | 91 | 3 | 10 | 17 | |
| 5130 | CD209 levels | PROLV000319 | 2.69e-03 | Protein levels | Myeloid | 67 | 2 | 8 | 10 | |
| 5131 | GPKOW levels | PROLV000925 | 2.65e-03 | Protein levels | Muscle / cardiac | 5 | 4 | 5 | 17 | |
| 5132 | Birth weight availability | MISCL000005 | 2.64e-03 | Miscellaneous | Neural / glial | 11 | 5 | 10 | 22 | |
| 5133 | CD300E/EFNA4 ratio | PRORT000431 | 2.63e-03 | Protein ratios | Lymphocyte | 75 | 2 | 10 | 17 | |
| 5134 | Viral wart | IMMUN000079 | 2.62e-03 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 5135 | CLEC4G/MERTK ratio | PRORT000661 | 2.61e-03 | Protein ratios | Myeloid | 78 | 5 | 18 | 29 | |
| 5136 | MGLL/STK4 ratio | PRORT001531 | 2.60e-03 | Protein ratios | Hepatocyte | 36 | 1 | 7 | 15 | |
| 5137 | CSF3 levels | PROLV000540 | 2.57e-03 | Protein levels | Myeloid | 40 | 2 | 7 | 9 | |
| 5138 | DRAXIN levels | PROLV000651 | 2.57e-03 | Protein levels | B / plasma cell | 29 | 2 | 7 | 16 | |
| 5139 | MAVS/TBL1X ratio | PRORT001501 | 2.57e-03 | Protein ratios | Lymphocyte | 1 | 2 | 14 | 35 | |
| 5140 | CST5 levels | PROLV000550 | 2.56e-03 | Protein levels | Gastrointestinal epithelium | 57 | 1 | 4 | 8 | |
| 5141 | LAMP3/PRSS8 ratio | PRORT001421 | 2.55e-03 | Protein ratios | Lymphocyte | 5 | 3 | 8 | 30 | |
| 5142 | SUSD4 levels | PROLV001980 | 2.51e-03 | Protein levels | Hepatocyte | 26 | 1 | 3 | 11 | |
| 5143 | IL5RA levels | PROLV001076 | 2.48e-03 | Protein levels | B / plasma cell | 181 | 3 | 12 | 28 | |
| 5144 | SPINT1/SUSD2 ratio | PRORT001810 | 2.46e-03 | Protein ratios | B / plasma cell | 20 | 1 | 6 | 7 | |
| 5145 | EBAG9/EDAR ratio | PRORT000957 | 2.45e-03 | Protein ratios | Myeloid | 27 | 4 | 12 | 16 | |
| 5146 | AMY1A or AMY1B or AMY1C levels | PROLV000089 | 2.43e-03 | Protein levels | Pancreatic epithelium | 33 | 0 | 7 | 9 | |
| 5147 | HLAE/IL15 ratio | PRORT001287 | 2.43e-03 | Protein ratios | Lymphocyte | 41 | 2 | 13 | 24 | |
| 5148 | DBNL/VASH1 ratio | PRORT000869 | 2.39e-03 | Protein ratios | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 5149 | F2R/TNFRSF14 ratio | PRORT001085 | 2.39e-03 | Protein ratios | Lymphocyte | 15 | 3 | 9 | 34 | |
| 5150 | CRELD2/HYOU1 ratio | PRORT000756 | 2.39e-03 | Protein ratios | Granulosa cell | 19 | 1 | 6 | 2 | |
| 5151 | CD48/SLAMF7 ratio | PRORT000465 | 2.39e-03 | Protein ratios | Lymphocyte | 35 | 4 | 17 | 42 | |
| 5152 | GP1BA/SELP ratio | PRORT001227 | 2.38e-03 | Protein ratios | Salivary epithelium | 3 | 2 | 8 | 11 | |
| 5153 | ACY1/DCXR ratio | PRORT000019 | 2.31e-03 | Protein ratios | Hepatocyte | 6 | 2 | 10 | 15 | |
| 5154 | TNFRSF13B/TNFRSF13C ratio | PRORT001846 | 2.31e-03 | Protein ratios | B / plasma cell | 23 | 4 | 9 | 15 | |
| 5155 | KLKB1 levels | PROLV001160 | 2.31e-03 | Protein levels | Hepatocyte | 103 | 2 | 7 | 17 | |
| 5156 | CES2 levels | PROLV000406 | 2.30e-03 | Protein levels | Myeloid | 38 | 2 | 10 | 11 | |
| 5157 | Sacroiliitis | MSKEL000020 | 2.29e-03 | Musculoskeletal | Muscle / cardiac | 35 | 4 | 9 | 31 | |
| 5158 | TNFRSF13B/TNFSF13B ratio | PRORT001848 | 2.28e-03 | Protein ratios | B / plasma cell | 5 | 2 | 9 | 14 | |
| 5159 | EDAR/YES1 ratio | PRORT000985 | 2.26e-03 | Protein ratios | Myeloid | 30 | 5 | 12 | 27 | |
| 5160 | CLEC4G/KEL ratio | PRORT000659 | 2.25e-03 | Protein ratios | Myeloid | 43 | 2 | 12 | 33 | |
| 5161 | Hypothyroidism, subclinical in pregnancy | ENDOC000016 | 2.22e-03 | Endocrine | Hematopoietic progenitor | 0 | 1 | 4 | 8 | |
| 5162 | FCRL1 levels | PROLV000783 | 2.20e-03 | Protein levels | B / plasma cell | 101 | 2 | 7 | 15 | |
| 5163 | APRT/EREG ratio | PRORT000134 | 2.19e-03 | Protein ratios | Myeloid | 4 | 2 | 11 | 23 | |
| 5164 | CRELD2/NUCB2 ratio | PRORT000757 | 2.19e-03 | Protein ratios | Epithelial | 38 | 1 | 6 | 15 | |
| 5165 | GP1BA/HBEGF ratio | PRORT001225 | 2.11e-03 | Protein ratios | Myeloid | 30 | 2 | 11 | 18 | |
| 5166 | CD40LG/EDAR ratio | PRORT000448 | 2.10e-03 | Protein ratios | Myeloid | 8 | 2 | 10 | 16 | |
| 5167 | REG1B/REG3A ratio | PRORT001732 | 2.08e-03 | Protein ratios | Gastrointestinal epithelium | 34 | 0 | 6 | 7 | |
| 5168 | EDAR/PRDX5 ratio | PRORT000974 | 2.08e-03 | Protein ratios | Myeloid | 42 | 2 | 10 | 16 | |
| 5169 | LYN/SIRT2 ratio | PRORT001472 | 2.06e-03 | Protein ratios | Lymphocyte | 5 | 1 | 5 | 11 | |
| 5170 | MYL3 levels | PROLV001360 | 2.04e-03 | Protein levels | Muscle / cardiac | 42 | 3 | 8 | 20 | |
| 5171 | DSC2 levels | PROLV000653 | 2.04e-03 | Protein levels | Epithelial | 35 | 0 | 8 | 8 | |
| 5172 | CNST/DOK2 ratio | PRORT000682 | 2.03e-03 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 15 | |
| 5173 | CD163/FOLR2 ratio | PRORT000380 | 2.01e-03 | Protein ratios | Myeloid | 56 | 4 | 12 | 18 | |
| 5174 | CLSTN3 levels | PROLV000465 | 2.01e-03 | Protein levels | Hepatocyte | 53 | 1 | 5 | 15 | |
| 5175 | KDM3A levels | PROLV001132 | 2.00e-03 | Protein levels | Lymphocyte | 21 | 2 | 16 | 40 | |
| 5176 | NID1/SORT1 ratio | PRORT001589 | 2.00e-03 | Protein ratios | Myeloid | 11 | 1 | 5 | 8 | |
| 5177 | OSCAR levels | PROLV001474 | 1.99e-03 | Protein levels | Hematopoietic progenitor | 181 | 4 | 9 | 11 | |
| 5178 | ERBB4/UMOD ratio | PRORT001048 | 1.94e-03 | Protein ratios | Hepatocyte | 23 | 1 | 7 | 12 | |
| 5179 | SEPTIN3 levels | PROLV001813 | 1.93e-03 | Protein levels | B / plasma cell | 64 | 3 | 5 | 25 | |
| 5180 | FCRL5/ICAM3 ratio | PRORT001133 | 1.92e-03 | Protein ratios | B / plasma cell | 52 | 4 | 21 | 31 | |
| 5181 | F2R/SEMA4D ratio | PRORT001080 | 1.90e-03 | Protein ratios | Muscle / cardiac | 0 | 4 | 10 | 15 | |
| 5182 | Free thyroxine | ENDOC000018 | 1.89e-03 | Endocrine | Hepatocyte | 8 | 3 | 9 | 12 | |
| 5183 | APBB1IP/NADK ratio | PRORT000114 | 1.88e-03 | Protein ratios | Myeloid | 2 | 2 | 7 | 10 | |
| 5184 | CD58/SIRPB1 ratio | PRORT000479 | 1.87e-03 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 2 | 5 | |
| 5185 | GGH levels | PROLV000882 | 1.85e-03 | Protein levels | Hepatocyte | 79 | 3 | 11 | 22 | |
| 5186 | OSM levels | PROLV001475 | 1.84e-03 | Protein levels | Myeloid | 82 | 3 | 10 | 22 | |
| 5187 | BLNK levels | PROLV000200 | 1.81e-03 | Protein levels | B / plasma cell | 0 | 3 | 15 | 27 | |
| 5188 | CA14 levels | PROLV000243 | 1.77e-03 | Protein levels | Muscle / cardiac | 52 | 2 | 7 | 12 | |
| 5189 | CRISP3 levels | PROLV000525 | 1.77e-03 | Protein levels | Hematopoietic progenitor | 88 | 3 | 9 | 12 | |
| 5190 | CD5/CD6 ratio | PRORT000466 | 1.76e-03 | Protein ratios | Myeloid | 22 | 4 | 11 | 17 | |
| 5191 | MAMDC4 levels | PROLV001259 | 1.76e-03 | Protein levels | Hepatocyte | 46 | 2 | 7 | 11 | |
| 5192 | CCN2/HBEGF ratio | PRORT000365 | 1.74e-03 | Protein ratios | Myeloid | 66 | 3 | 14 | 13 | |
| 5193 | DLL1/NBL1 ratio | PRORT000916 | 1.72e-03 | Protein ratios | Lymphocyte | 6 | 1 | 6 | 16 | |
| 5194 | CD244/TREML2 ratio | PRORT000410 | 1.72e-03 | Protein ratios | Myeloid | 33 | 5 | 16 | 23 | |
| 5195 | MCTS1 levels | PROLV001287 | 1.70e-03 | Protein levels | Myeloid | 59 | 3 | 10 | 14 | |
| 5196 | DAB2/ERBIN ratio | PRORT000835 | 1.65e-03 | Protein ratios | Muscle / cardiac | 0 | 5 | 15 | 36 | |
| 5197 | APBB1IP levels | PROLV000112 | 1.64e-03 | Protein levels | Myeloid | 38 | 4 | 17 | 27 | |
| 5198 | BSG/LY9 ratio | PRORT000249 | 1.64e-03 | Protein ratios | B / plasma cell | 12 | 1 | 6 | 19 | |
| 5199 | IL2RA levels | PROLV001069 | 1.63e-03 | Protein levels | B / plasma cell | 106 | 3 | 16 | 27 | |
| 5200 | PIGR levels | PROLV001556 | 1.63e-03 | Protein levels | Hepatocyte | 58 | 2 | 11 | 16 | |
| 5201 | CCL5/SELP ratio | PRORT000358 | 1.62e-03 | Protein ratios | Lymphocyte | 2 | 1 | 6 | 32 | |
| 5202 | PRTN3 levels | PROLV001651 | 1.61e-03 | Protein levels | Myeloid | 93 | 1 | 5 | 9 | |
| 5203 | EDAR/ENO2 ratio | PRORT000966 | 1.61e-03 | Protein ratios | Myeloid | 31 | 4 | 7 | 19 | |
| 5204 | REG1A/REG3A ratio | PRORT001729 | 1.59e-03 | Protein ratios | Gastrointestinal epithelium | 34 | 0 | 6 | 7 | |
| 5205 | HNRNPK/VASH1 ratio | PRORT001294 | 1.59e-03 | Protein ratios | Myeloid | 1 | 1 | 6 | 9 | |
| 5206 | GOLM2 levels | PROLV000909 | 1.54e-03 | Protein levels | Myeloid | 155 | 2 | 9 | 8 | |
| 5207 | DBNL/EDAR ratio | PRORT000865 | 1.52e-03 | Protein ratios | Myeloid | 31 | 4 | 14 | 22 | |
| 5208 | CD69/CHMP1A ratio | PRORT000489 | 1.52e-03 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 5 | 13 | |
| 5209 | CD5L levels | PROLV000348 | 1.52e-03 | Protein levels | B / plasma cell | 208 | 2 | 11 | 26 | |
| 5210 | ICAM3/TNFRSF13B ratio | PRORT001329 | 1.50e-03 | Protein ratios | B / plasma cell | 40 | 1 | 7 | 6 | |
| 5211 | CRTAM levels | PROLV000530 | 1.46e-03 | Protein levels | Lymphocyte | 122 | 2 | 13 | 20 | |
| 5212 | DAG1/HBEGF ratio | PRORT000848 | 1.45e-03 | Protein ratios | Myeloid | 61 | 2 | 10 | 15 | |
| 5213 | BAG6/BMP6 ratio | PRORT000200 | 1.45e-03 | Protein ratios | Hepatocyte | 21 | 3 | 12 | 38 | |
| 5214 | DEFA1 or DEFA1B levels | PROLV000613 | 1.45e-03 | Protein levels | Myeloid | 56 | 1 | 6 | 5 | |
| 5215 | CD48/CRTAM ratio | PRORT000463 | 1.42e-03 | Protein ratios | Lymphocyte | 45 | 2 | 15 | 25 | |
| 5216 | ERBB2/GUSB ratio | PRORT001043 | 1.37e-03 | Protein ratios | Hepatocyte | 25 | 3 | 13 | 29 | |
| 5217 | METAP2/RILP ratio | PRORT001525 | 1.36e-03 | Protein ratios | Myeloid | 0 | 3 | 11 | 18 | |
| 5218 | CRISP2 levels | PROLV000524 | 1.33e-03 | Protein levels | Lymphocyte | 3 | 1 | 9 | 12 | |
| 5219 | IFNLR1 levels | PROLV001022 | 1.33e-03 | Protein levels | Hepatocyte | 49 | 2 | 7 | 19 | |
| 5220 | CTSB levels | PROLV000560 | 1.32e-03 | Protein levels | Myeloid | 144 | 3 | 10 | 13 | |
| 5221 | LAYN/ULBP2 ratio | PRORT001435 | 1.30e-03 | Protein ratios | Neural / glial | 3 | 1 | 8 | 13 | |
| 5222 | CXCL5/EDAR ratio | PRORT000827 | 1.29e-03 | Protein ratios | Myeloid | 9 | 3 | 10 | 24 | |
| 5223 | KEL levels | PROLV001134 | 1.27e-03 | Protein levels | Hepatocyte | 60 | 3 | 15 | 28 | |
| 5224 | HBEGF/PDGFB ratio | PRORT001269 | 1.27e-03 | Protein ratios | Myeloid | 32 | 1 | 5 | 14 | |
| 5225 | MYLPF levels | PROLV001361 | 1.25e-03 | Protein levels | Muscle / cardiac | 1 | 2 | 9 | 17 | |
| 5226 | FGF2/HBEGF ratio | PRORT001140 | 1.25e-03 | Protein ratios | Myeloid | 42 | 2 | 8 | 12 | |
| 5227 | GHRL levels | PROLV000886 | 1.25e-03 | Protein levels | Hepatocyte | 39 | 2 | 6 | 15 | |
| 5228 | LY9 levels | PROLV001249 | 1.24e-03 | Protein levels | Myeloid | 87 | 1 | 6 | 12 | |
| 5229 | Hypothyroidism, autoimmune | IMMUN000015 | 1.23e-03 | Immunologic | Lymphocyte | 218 | 2 | 11 | 15 | |
| 5230 | CRTAM/VCAM1 ratio | PRORT000775 | 1.23e-03 | Protein ratios | Lymphocyte | 13 | 2 | 15 | 27 | |
| 5231 | Bilirubin metabolism disorder | HPBIL000003 | 1.21e-03 | Hepatopancreatobiliary | Hepatocyte | 20 | 2 | 9 | 16 | |
| 5232 | TNFRSF13C/TNFSF13B ratio | PRORT001849 | 1.19e-03 | Protein ratios | B / plasma cell | 32 | 3 | 7 | 28 | |
| 5233 | NADK/PXN ratio | PRORT001570 | 1.17e-03 | Protein ratios | Granulosa cell | 0 | 1 | 5 | 5 | |
| 5234 | TNFRSF6B levels | PROLV002072 | 1.16e-03 | Protein levels | B / plasma cell | 32 | 2 | 8 | 11 | |
| 5235 | ADGRE5/SEMA7A ratio | PRORT000033 | 1.14e-03 | Protein ratios | Myeloid | 18 | 2 | 6 | 13 | |
| 5236 | IL5RA/TNFRSF13B ratio | PRORT001352 | 1.13e-03 | Protein ratios | B / plasma cell | 63 | 3 | 16 | 21 | |
| 5237 | PRG3 levels | PROLV001629 | 1.13e-03 | Protein levels | Lymphocyte | 126 | 2 | 8 | 27 | |
| 5238 | PDCD1 levels | PROLV001515 | 1.11e-03 | Protein levels | Lymphocyte | 69 | 2 | 13 | 19 | |
| 5239 | EDAR/F11R ratio | PRORT000968 | 1.07e-03 | Protein ratios | Myeloid | 23 | 3 | 7 | 20 | |
| 5240 | CD244/CRTAM ratio | PRORT000406 | 1.06e-03 | Protein ratios | Lymphocyte | 30 | 2 | 14 | 25 | |
| 5241 | ST6GAL1 levels | PROLV001953 | 1.05e-03 | Protein levels | Myeloid | 81 | 3 | 11 | 16 | |
| 5242 | DAG1/F2R ratio | PRORT000846 | 1.04e-03 | Protein ratios | Myeloid | 18 | 3 | 8 | 18 | |
| 5243 | FASLG levels | PROLV000771 | 1.03e-03 | Protein levels | Myeloid | 149 | 2 | 14 | 29 | |
| 5244 | ICAM3/SLAMF7 ratio | PRORT001328 | 1.03e-03 | Protein ratios | Myeloid | 27 | 3 | 19 | 22 | |
| 5245 | DAPP1/ITGB1BP2 ratio | PRORT000854 | 9.89e-04 | Protein ratios | Myeloid | 21 | 5 | 19 | 31 | |
| 5246 | ARHGAP30 levels | PROLV000137 | 9.80e-04 | Protein levels | Lymphocyte | 10 | 3 | 12 | 40 | |
| 5247 | GALNT5 levels | PROLV000851 | 9.73e-04 | Protein levels | Hematopoietic progenitor | 44 | 4 | 7 | 15 | |
| 5248 | FAM3B/FUT3_FUT5 ratio | PRORT001112 | 9.35e-04 | Protein ratios | Hepatocyte | 18 | 2 | 10 | 19 | |
| 5249 | CKAP4/TNFRSF4 ratio | PRORT000624 | 9.23e-04 | Protein ratios | Hepatocyte | 21 | 2 | 10 | 35 | |
| 5250 | CXCL5/PLXNA4 ratio | PRORT000829 | 9.16e-04 | Protein ratios | Myeloid | 0 | 5 | 14 | 31 | |
| 5251 | RNASET2 levels | PROLV001742 | 9.09e-04 | Protein levels | Myeloid | 94 | 2 | 9 | 15 | |
| 5252 | CD6/EZR ratio | PRORT000484 | 8.85e-04 | Protein ratios | Myeloid | 15 | 5 | 18 | 43 | |
| 5253 | EDAR/SERPINB1 ratio | PRORT000977 | 8.57e-04 | Protein ratios | Myeloid | 29 | 2 | 8 | 14 | |
| 5254 | EPHB6/VWC2 ratio | PRORT001039 | 8.16e-04 | Protein ratios | B / plasma cell | 2 | 4 | 11 | 20 | |
| 5255 | GDF15 levels | PROLV000869 | 8.01e-04 | Protein levels | Hepatocyte | 7 | 1 | 8 | 27 | |
| 5256 | TPSAB1 levels | PROLV002099 | 7.68e-04 | Protein levels | Lymphocyte | 33 | 2 | 14 | 25 | |
| 5257 | SLAMF7 levels | PROLV001876 | 7.66e-04 | Protein levels | Myeloid | 126 | 3 | 7 | 14 | |
| 5258 | APP/HBEGF ratio | PRORT000126 | 7.54e-04 | Protein ratios | Myeloid | 46 | 5 | 17 | 26 | |
| 5259 | HBEGF/SDC4 ratio | PRORT001271 | 7.49e-04 | Protein ratios | Myeloid | 56 | 2 | 9 | 18 | |
| 5260 | NFATC1/SPRY2 ratio | PRORT001586 | 7.47e-04 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 32 | |
| 5261 | CXCL11/SDC4 ratio | PRORT000819 | 7.41e-04 | Protein ratios | Myeloid | 15 | 4 | 10 | 19 | |
| 5262 | VSTM1 levels | PROLV002174 | 7.29e-04 | Protein levels | Myeloid | 60 | 3 | 7 | 13 | |
| 5263 | CXCL11/DKK1 ratio | PRORT000817 | 7.26e-04 | Protein ratios | Myeloid | 13 | 4 | 15 | 21 | |
| 5264 | TNF levels | PROLV002053 | 7.20e-04 | Protein levels | Lymphocyte | 30 | 2 | 10 | 20 | |
| 5265 | EZR levels | PROLV000739 | 7.00e-04 | Protein levels | Myeloid | 46 | 3 | 15 | 27 | |
| 5266 | EFNA4 levels | PROLV000682 | 6.95e-04 | Protein levels | Lymphocyte | 16 | 1 | 9 | 21 | |
| 5267 | FCAR levels | PROLV000775 | 6.63e-04 | Protein levels | Myeloid | 87 | 2 | 7 | 13 | |
| 5268 | CD6 levels | PROLV000349 | 6.32e-04 | Protein levels | Lymphocyte | 89 | 2 | 19 | 32 | |
| 5269 | MMP8/OLR1 ratio | PRORT001543 | 6.12e-04 | Protein ratios | Myeloid | 9 | 3 | 10 | 21 | |
| 5270 | KLRD1 levels | PROLV001162 | 5.71e-04 | Protein levels | Myeloid | 163 | 2 | 11 | 15 | |
| 5271 | CD72 levels | PROLV000354 | 5.70e-04 | Protein levels | B / plasma cell | 84 | 2 | 12 | 31 | |
| 5272 | IL16/NADK ratio | PRORT001345 | 5.69e-04 | Protein ratios | Myeloid | 4 | 2 | 7 | 21 | |
| 5273 | CC2D1A/STAMBP ratio | PRORT000328 | 5.58e-04 | Protein ratios | Lymphocyte | 1 | 1 | 15 | 21 | |
| 5274 | TNFRSF13C levels | PROLV002064 | 5.53e-04 | Protein levels | B / plasma cell | 45 | 3 | 7 | 22 | |
| 5275 | ADA2 levels | PROLV000024 | 4.39e-04 | Protein levels | Myeloid | 151 | 3 | 10 | 14 | |
| 5276 | ICAM3 levels | PROLV001006 | 4.13e-04 | Protein levels | B / plasma cell | 143 | 2 | 12 | 18 | |
| 5277 | VMO1 levels | PROLV002163 | 3.81e-04 | Protein levels | Myeloid | 67 | 4 | 12 | 14 | |
| 5278 | GCNT1 levels | PROLV000868 | 3.72e-04 | Protein levels | Myeloid | 33 | 0 | 4 | 12 | |
| 5279 | APBB1IP/POLR2F ratio | PRORT000115 | 2.92e-04 | Protein ratios | Myeloid | 11 | 3 | 20 | 34 | |
| 5280 | PRG2 levels | PROLV001628 | 2.70e-04 | Protein levels | Lymphocyte | 70 | 4 | 8 | 35 | |
| 5281 | MANSC1/PODXL2 ratio | PRORT001484 | 2.62e-04 | Protein ratios | Hepatocyte | 3 | 2 | 10 | 22 | |
| 5282 | CLEC4G levels | PROLV000453 | 2.56e-04 | Protein levels | Myeloid | 82 | 3 | 10 | 17 | |
| 5283 | CLEC4C levels | PROLV000451 | 2.52e-04 | Protein levels | Myeloid | 124 | 4 | 9 | 15 | |
| 5284 | ADAM8 levels | PROLV000029 | 2.39e-04 | Protein levels | Myeloid | 76 | 3 | 8 | 14 | |
| 5285 | TG levels | PROLV002018 | 2.06e-04 | Protein levels | Gastrointestinal epithelium | 11 | 0 | 9 | 10 | |
| 5286 | CLEC7A levels | PROLV000457 | 2.06e-04 | Protein levels | Myeloid | 64 | 1 | 5 | 15 | |
| 5287 | S100P levels | PROLV001773 | 9.18e-05 | Protein levels | Myeloid | 20 | 4 | 10 | 14 | |
| 5288 | CEBPB/NADK ratio | PRORT000591 | 2.32e-05 | Protein ratios | Myeloid | 1 | 1 | 6 | 15 |